price
AC
NASDAQ · ACRS
Aclaris Therapeutics, Inc.
Healthcare · Medical - Diagnostics & Research
$6.16
Down-$0.15 (-2.44%)
Updated Aug 28, 2026, 6:24 PM
SID Score
7.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 310.95M
- P/E ratio
- -5.42
- Dividend yield
- 0.00%
- 52-week range
- $1.74 – $6.60
- Volume
- 1.41M
- Avg. volume
- 1.84M
Price performance
ACRS price history
1M range · 21 trading sessions · Daily adjusted prices
ACRS closed at $6.16 after 21 trading sessions, up 15.79% for the selected period.
- Last close
- $6.16
- Period change
- +15.79%
- Period low
- $5.20
- Period high
- $6.54
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 27, 2026 | $6.15 | $6.305 | $6.12 | $6.16 | 1.41M |
| Aug 26, 2026 | $6.53 | $6.53 | $6.07 | $6.19 | 1.74M |
| Aug 25, 2026 | $6.36 | $6.5999 | $6.15 | $6.535 | 3.35M |
| Aug 24, 2026 | $6.35 | $6.40 | $6.02 | $6.31 | 1.27M |
| Aug 21, 2026 | $6.36 | $6.50 | $6.29 | $6.41 | 2.21M |
| Aug 20, 2026 | $6.35 | $6.46 | $6.17 | $6.33 | 1.51M |
| Aug 19, 2026 | $6.40 | $6.4487 | $6.20 | $6.44 | 2.07M |
| Aug 18, 2026 | $5.88 | $6.315 | $5.854 | $6.305 | 2.01M |
| Aug 17, 2026 | $5.72 | $5.955 | $5.685 | $5.92 | 1.09M |
| Aug 14, 2026 | $5.82 | $5.855 | $5.64 | $5.78 | 666.27K |
| Aug 13, 2026 | $5.90 | $6.055 | $5.812 | $5.86 | 1.07M |
| Aug 12, 2026 | $5.94 | $5.97 | $5.84 | $5.84 | 937.11K |
| Aug 11, 2026 | $5.90 | $5.935 | $5.80 | $5.92 | 1.21M |
| Aug 10, 2026 | $5.92 | $5.99 | $5.67 | $5.90 | 1.59M |
| Aug 7, 2026 | $6.08 | $6.23 | $5.65 | $5.91 | 2.39M |
| Aug 6, 2026 | $6.34 | $6.44 | $5.90 | $6.09 | 2.82M |
| Aug 5, 2026 | $5.99 | $6.515 | $5.91 | $6.36 | 5.68M |
| Aug 4, 2026 | $5.63 | $6.045 | $5.59 | $5.98 | 2.58M |
| Aug 3, 2026 | $5.19 | $5.55 | $5.0103 | $5.53 | 1.95M |
| Jul 31, 2026 | $5.30 | $5.34 | $5.095 | $5.20 | 1.64M |
| Jul 30, 2026 | $5.13 | $5.43 | $5.01 | $5.32 | 1.91M |
Latest ACRS news
The latest Smart Investors Daily articles mentioning ACRS.
Stock researchResearch & News · Analysis
Loading stock research…